Up 43% In A Month, Will UniQure Stock See Further Gains? 0 12.07.2022 12:45 Forbes.com This can be attributed to the company reporting positive findings from clinical trials for its Huntington’s Disease treatment - AMT-130. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
